FAM
TMO icon

Fulcrum Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Fulcrum Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,747
Closed -$2.99M – 356
2025
Q1 		$2.99M Buy
+7,747
New +$4.2M 0.58% 47

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fulcrum Asset Management's TMO Position: Q1 2026 in Review

Fulcrum Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2026, buying an estimated $53.7K and bringing the position to 7,907 shares worth $3.8M. The position accounts for 0.57% of the portfolio, ranked #53.

Fulcrum Asset Management first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.56M in Q4 2025. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fulcrum Asset Management held 7,907 shares of Thermo Fisher Scientific worth $3.8M as of Q1 2026.
  • Fulcrum Asset Management bought 99 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.7K.
  • Thermo Fisher Scientific made up 0.57% of Fulcrum Asset Management's portfolio in Q1 2026, its #53 holding.
  • Fulcrum Asset Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • Fulcrum Asset Management's Thermo Fisher Scientific position peaked at $4.56M in Q4 2025.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.